ArticlePain reports2025
Cost-effectiveness analysis of active day patient treatment, an interdisciplinary pain self-management program.
Article in Pain reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Active day patient treatment (ADAPT) is an interdisciplinary, multimodal pain management program for patients with disabling chronic pain at the Pain Management & Research Centre (PMRC), Royal North Shore Hospital in Sydney, Australia. Objective: The aim of this study was to analyse the cost-effectiveness of ADAPT using hospital administrative and patient reported >12-month follow-up data. Patients' preprogram labour force participation, health care utilization costs, and quality of life outcomes were compared with outcomes >12 months after participating the program. Methods: This retrospective cohort study included 61 patients who completed ADAPT (including follow-up) between 2014 and 2017 at the PMRC. Primary outcome measures were labour force participation in patients' average weekly earnings (n = 61) and incremental cost-effectiveness ratio (ICERs) (n = 53) based on the health utility score derived from assessment of quality of life (AQoL-8D). Pain-related health care utilization and costs before and >12 months after the program were assessed to calculate the ICER. Results: We estimated patients were earning $628.99 per week at >12 month after participating in ADAPT comparing to $539.54 at baseline. The ICER was $20,228.76 (95% CI: $14,176.25-$27,826.33) per quality adjusted life years gained. Conclusion: Results from this study indicated that, patients with chronic pain >12 months after participating in ADAPT reported higher quality of life scores along with reduced health care utilization costs. However, more robust and exhaustive studies, especially prospective studies, are required to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.